XOMA - XOMA Corporation

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
32.50
-0.78 (-2.34%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close33.28
Open33.50
Bid30.08 x 100
Ask39.95 x 200
Day's Range32.05 - 33.98
52 Week Range3.96 - 34.18
Volume201,799
Avg. Volume195,951
Market Cap264.683M
Beta2.82
PE Ratio (TTM)N/A
EPS (TTM)-1.53
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.50
Trade prices are not sourced from all markets
  • ACCESSWIRE3 days ago

    Today’s Research Reports on Stocks to Watch: Halozyme Therapeutics and Xoma Corporation

    NEW YORK, NY / ACCESSWIRE / December 8, 2017 / Halozyme Therapuetics and XOMA Corporation both hit brand new highs during intra-day trading yesterday. Halozyme announced a collaboration and license agreement ...

  • GlobeNewswire3 days ago

    XOMA Announces Exclusive License Agreement for XOMA 358 with Rezolute, Inc.

    Expands portfolio of partner-funded programs $240 million in potential milestone payments Royalties ranging from the high single-digits to mid-teens on net sales Beyond XOMA 358, XOMA adds three additional ...

  • GlobeNewswire3 days ago

    AntriaBio Announces Exclusive License Agreement for a Phase 2 Orphan Disease Therapy with XOMA Corporation and Name Change to Rezolute, Inc.

    LOUISVILLE, Colo., Dec. 07, 2017-- Rezolute, Inc., a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies for metabolic and orphan diseases, and XOMA Corporation, ...

  • 4 Biotech Stocks to Better Your Financial Health This Winter
    Zacks9 days ago

    4 Biotech Stocks to Better Your Financial Health This Winter

    The biotech industry shows a solid performance so far this year except for a brief slump in between of late. However, it is a good idea to select stocks from a sector that is fundamentally strong.

  • Capital Cube10 days ago

    ETFs with exposure to XOMA Corp. : November 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to XOMA Corp. Here are 5 ETFs with the largest exposure to XOMA-US. Comparing the performance and risk of XOMA Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • XOMA Corp. :XOMA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
    Capital Cube11 days ago

    XOMA Corp. :XOMA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017

    Categories: Yahoo FinanceGet free summary analysis XOMA Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of XOMA Corp. – Emergent BioSolutions Inc., Novartis AG Sponsored ADR, Regeneron Pharmaceuticals, Inc., pSivida Corp., Pfizer Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Limited Sponsored ADR and AbbVie, ... Read more (Read more...)

  • Forbeslast month

    Xoma: A Lower Risk Way Of Investing In Biotech

    Biotech stocks have been big winners this year. But since they can lose 50% in a single day, readers have asked if there is a "safer" way to invest. Bruce Pile tells us about Ligand Pharmaceuticals and Xoma Corp., two biotechs that do not bet the whole company on a single drug candidate.

  • Associated Presslast month

    Xoma beats 3Q profit forecasts

    The Berkeley, California-based company said it had net income of $1.98 per share. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...

  • 3 Biotech Stocks That Turned $1,000 Into More Than $5,000 This Year
    Motley Foollast month

    3 Biotech Stocks That Turned $1,000 Into More Than $5,000 This Year

    These three biotech stocks helped a lot of investors get rich this year. Are there more gains ahead?

  • GlobeNewswire2 months ago

    XOMA Announces Multiple New License Agreements for Proprietary Phage Display Libraries

    BERKELEY, Calif., Oct. 04, 2017-- XOMA Corporation, a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced it has entered into new non-exclusive license agreements ...

  • GlobeNewswire3 months ago

    XOMA to Present at the Cantor Fitzgerald Global Healthcare Conference

    BERKELEY, Calif., Sept. 19, 2017-- XOMA Corporation, a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced that Jim Neal, Chief Executive Officer, will present ...

  • Capital Cube3 months ago

    ETFs with exposure to XOMA Corp. : September 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to XOMA Corp. Here are 5 ETFs with the largest exposure to XOMA-US. Comparing the performance and risk of XOMA Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ACCESSWIRE3 months ago

    Today's Research Reports on Stocks to Watch: Insmed Inc. and XOMA Corporation

    NEW YORK, NY / ACCESSWIRE / September 6, 2017 / XOMA and Insmed both saw their shares blast off on Tuesday. XOMA gained nearly 44% after being upgraded by Wedbush on account of the company announcing that ...

  • ACCESSWIRE3 months ago

    Today's Research Reports on Stocks to Watch: Adamas Pharmaceuticals and XOMA Corporation

    NEW YORK, NY / ACCESSWIRE / August 28, 2017 / Adamas Pharmaceuticals was a big winner in Friday trading after the company received FDA approval of Gocovri, a Parkinson's drug that is the first of its kind ...

  • Capital Cube4 months ago

    ETFs with exposure to XOMA Corp. : August 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to XOMA Corp. Here are 5 ETFs with the largest exposure to XOMA-US. Comparing the performance and risk of XOMA Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • XOMA Corp. :XOMA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
    Capital Cube4 months ago

    XOMA Corp. :XOMA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017

    Categories: Yahoo FinanceGet free summary analysis XOMA Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of XOMA Corp. – Emergent BioSolutions Inc., Novartis AG Sponsored ADR, Teva Pharmaceutical Industries Limited Sponsored ADR, Pfizer Inc., AbbVie, Inc., Eli Lilly and Company and Regeneron Pharmaceuticals, Inc. (EBS-US, ... Read more (Read more...)

  • Associated Press7 months ago

    Xoma reports 1Q loss

    The Berkeley, California-based company said it had a loss of $2.37 per share. Losses, adjusted to extinguish debt, were $2.30 per share. The drug developer posted revenue of $260,000 in the period. Xoma ...